Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome

Journal of Cardiovascular Electrophysiology

Volumn 19, Issue 1, 2008, Pages 95-97

  Pellizzón, Oscar A ^a   Kalaizich, Luis ^a   Ptáček, Louis J ^b   Tristani Firouzi, Martin ^b   Gonzalez, Mario D ^c,d  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Andersen Tawil syndrome; Bidirectional ventricular tachycardia; Flecainide; Long QT syndrome

Indexed keywords

DILTIAZEM; FLECAINIDE; LIDOCAINE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; PROPRANOLOL;

ADOLESCENT; ANDERSEN SYNDROME; ARTICLE; CARDIOMYOPATHY; CASE REPORT; CONGESTIVE HEART FAILURE; DRUG DOSE INCREASE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; TREATMENT OUTCOME;

ADOLESCENT; ANDERSEN SYNDROME; ANTI-ARRHYTHMIA AGENTS; CARDIOMYOPATHIES; FEMALE; FLECAINIDE; HUMANS; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 37549049378     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2007.00910.x     Document Type: Article

References (13)

1. Schwensen C : Ventricular tachycardia as the result of the administration of digitalis. Heart 1922 9 : 199 203.
2. Rosenbaum MB, Elizari MV, Lazzari JO : The mechanism of bidirectional tachycardia. Am Heart J 1969 78 : 4 12.
3. Martini B, Buja GF, Canciani B, Nava A : Bidirectional tachycardia: A sustained form, not related to digitalis intoxication, in an adult without apparent cardiac disease. Jpn Heart J 1988 29 : 381 87.
4. Plaster NM, Tawil R, Tristani-Firouzi M, Canún S, Bendahhou S, Tsunoda A, Donaldson MR, Iannaccone ST, Brunt E, Barohn R, Clark J, Deymeer F, George AL Jr., Fish FA, Hahn A, Situ A, Ozdemir C, Serdaroglu P, Subramony SH, Wolfe G, Fu YH, Ptáček LJ : Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen syndrome. Cell 2001 105 : 511 519.
5. Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone V, Meola G, Hahn A, Bendahhou S, Kwiecinski H, Fidzianska A, Plaster N, Fu YH, Ptacek LJ, Tawil R : Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 2002 110 : 381 388.
6. Andersen ED, Krasilnikoff PA, Overad H : Intermittent muscular weakness, extrasystoles, and multiple developmental abnormalities: A new syndrome? Acta Paediatr Scand 1971 60 : 559 564.
7. Tawil R, Ptacek LJ, Pavlakis SG, DeVivo DC, Penn AS, Ozdemir C, Griggs RC : Andersen's syndrome: Potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann Neurol 1994 35 : 326 330.
8. Peters S, Schulze-Bahr E, Peters S, Etheridge SP, Tristani-Firouzi M : Sudden death in Andersen-Tawil syndrome. Europace 2007 9 : 162 166.
9. Moss AJ, Kass RS : Long QT syndrome: From channels to cardiac arrhythmias. J Clin Invest 2005 115 : 2018 2024.
10. Bokenkamp R, Wilde AA, Schalij MJ, Blom NA : Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome. Heart Rhythm 2007 4 : 508 511.
11. Gonzalez MD, Vassalle M : Role of oscillatory potential and pacemaker shifts in digitalis intoxication of the sinoatrial node. Circulation 1993 87 : 1705 1714.
12. Ito K, Nagafuchi K, Taga A, Yorikane R, Koike H : Possible involvement of altered Na+Ca2+ exchange in negative inotropic effects of class I antiarrhythmic drugs on rabbit and rat ventricles. J Cardiovasc Pharmacol 1996 26 : 355 361.
13. Takahara A, Sugiyama A, Hashimoto K : Effects of class I antiarrhythmic drugs on the digitalis-induced triggered activity arrhythmia model: A rationale for the short-term use of class I drugs against triggered arrhythmias. Heart Vessels 2004 19 : 43 48.